AIM WINNERS & LOSERS: OptiBiotix and Ixico rise on deal wins

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The following stocks are the leading risers and fallers on AIM on Monday.

----------

AIM - WINNERS

----------

OptiBiotix Health PLC, up 7.4% at 8.32 pence, 12-month range 7.50p-23.50p. The life sciences firm has won a deal with a ‘well-known weight management company’. OptiBiotix, which makes products aimed at reducing food cravings, says the deal is in the low six-figures.

----------

Ixico PLC, up 7.0% at 11.50p, 12-month range 7.35p-15.00p. The medical research company has won a contract with a global pharmaceutical company to provide imaging services for a phase 3 trial in Huntington’s Disease. The deal is worth £3.5 million over four years.

----------

AIM - LOSERS

----------

Polar Capital Holdings PLC, down 4.0% at 526.00p, 12-month range 340.50p-590.00p. The fund manager reports a rise in assets under management but notes ‘the macro environment is uncertain and likely to remain volatile’. Assets under management at September 30 were up 25% at £26.7 billion at the September 30 half-year end, from £21.4 billion in March. Net outflows during the period, however, total £690 million, compared to inflows of £472 million a year prior. The AuM increase, which took it to an all-time high, stemmed from a £6.3 billion boost from investment performance and market movement, Polar Capital says.

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.